Ingolf Cascorbi is Professor of Pharmacology and Vice Dean of Studies at the Medical Faculty, University of Kiel and Director of the Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Campus Kiel, Germany. He holds a PhD in biochemistry, an MD and is specialist in clinical pharmacology. His research interests are in variability in drug response, in particular in pharmacogenomics and -epigenomics and mechanisms of drug resistance in oncology. Ingolf Cascorbi is President of the International Union of Basic and Clinical Pharmacology IUPHAR (2018-2024)), President of the German Society of Experimental and Clinical Pharmacology DGPT (2020 and 2023) and Chairman of the German Society of Clinical Pharmacology and Therapeutics DGKliPha (2019-2024). He is member of various scientific and editorial Boards i.e. since 2012 Associate Editor of ‘Clinical Pharmacology and Therapeutics’.
